Beacon Pointe Advisors, LLC Gsk PLC Transaction History

Beacon Pointe Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $1.76 Million - $2 Million	-41,789 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$40.23 - $47.74 $944,117 - $1.12 Million	23,468 Added 128.09%	41,789 $1.82 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $508,083 - $592,111	13,068 Added 248.77%	18,321 $808,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $838,174 - $932,601	-21,608 Reduced 80.44%	5,253 $201,000
Q2 2021 Aug 17, 2021	BUY	$36.52 - $41.46 $980,963 - $1.11 Million	26,861 New	26,861 $1.07 Million
Q1 2021 May 18, 2021	SELL	$34.27 - $40.01 $673,816 - $786,676	-19,662 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $463,045 - $542,824	13,591 Added 223.87%	19,662 $725,000
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $175,077 - $197,496	-4,594 Reduced 43.08%	6,071 $229,000
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $403,883 - $464,780	10,665 New	10,665 $435,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $150,563 - $226,424	-4,637 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $194,754 - $223,735	4,637 New	4,637 $217,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.